Videos | Bringing pharma’s top innovators to your screen

Skip to main content

Thursday 28 May 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

R&D

Happy patient and HCP

Sponsored

IQVIA on reducing complexity and workload for clinical trial...

R&D

hVIVO Future of RSV research

Sponsored

Rethinking clinical research: The case for human challenge t...

Digital

Interview at Reuters Pharma EU with Florian Schnappauf, Veeva

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

R&D

Interview at LSX 2026 with Paulo Neves

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

R&D

Interview at LSX2026 Mike Cooke

LSX2026: Non-opioid pain relief and pharma positivity, with ...

Mike Cooke, CEO of AmacaThera, spoke with pharmaphorum at the LSX World Congress, including about non-opioid pain relief.

Oncology

Greg Deener at CAR-TCR

CAR-TCR 2023 – Greg Deener

In late August, pharmaphorum traveled to Boston to cover CAR-TCR, a conference dedicated to the fast-moving cell therapy space.

Digital

Health Innovators Remepy

Health Innovators – Or Shoval and Shahar Shelly

Why do the same medications work well in some patients and poorly in others? One reason might be the poorly understood connection between mind and body.

Oncology

Artwork on display

Health Innovators – Dr Jack Hoppin and Dr John Babich (follo...

The last time we checked in on Ratio Therapeutics co-founders Dr Jack Hoppin and Dr John Babich, they were working out of a WeWork co-working space in downtown Boston, just beginning their

Load more results

Sales & Marketing

Sales & Marketing

Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Sales & Marketing

Interview at JPM26 with Helen Sabzevari and Greg Skalicky

Rewiring commercialisation to meet the moment, with Helen Sa...

At the Informa Biotech Showcase at JPM2026, EVERSANA President Greg Skalicky and Helen Sabzevari, CEO of Precigen, discuss new commercialisation.

Digital

Digital

Interview at Reuters Pharma EU with Florian Schnappauf, Veeva

From data to deployment: Navigating AI adoption in pharma wi...

Explore our video interview for expert tips on AI adoption in pharma, featuring Veeva.

Digital

Inizio Ignite, STEM AI video feature image

Sponsored

STEM AI: Delivering intelligent data-led HCP interactions

In a new sponsored video, pharmaphorum spoke with experts from STEM, an Inizio Ignite company, about STEM AI

Market Access

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Market Access

Interview with Marjorie Sidhoum at BIO Europe 2026

BIO-Europe Spring 2026: In conversation with Marjorie Sidhou...

Marjorie Sidhoum, vice president of business development & corporate communication at Kainova Therapeutics, discusses their immuno-oncology pipeline.

Editor's Picks

GBL joins CVC in €10.7bn takeover bid for Recordati

After refusing to resign, CDER head Høeg is fired

As Ebola deaths climb, search begins for vaccine

NICE changes stance on Genmab's cervical cancer drug

Remepy's hybrid Parkinson's therapy poised for phase 3

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Interview at LSX 2026 with Roi Raz

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Oncology

Interview with Vicky Brown at Pharma USA 2026

Hernexeos and what’s next, with Vicky Brown

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent US approval for Hernexeos in NSCLC.

Oncology

Interview at JPM26 with Ben Zeskind

A cancer treatment modality that prioritises QoL, with Ben Z...

Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.

Patients

Patients

Interview with Matt Wadyka at Reuters Pharma USA 2026

Making direct-to-patient work, with Matt Wadyka

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Patients

Interview at LSX 2026 with Hans Schambye

LSX2026: On promise and patience, with Hans Schambye

At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.

Patients

Interview with Phil Johnson at Pharma US 26

Using patient data to fill in GLP-1 blind spots, with Phil J...

At Reuters Pharma USA, Evidation Health's Phil Johnson talks about what pharma needs to know about their GLP-1 patients and how better data can help.

R&D

R&D

Happy patient and HCP

Sponsored

IQVIA on reducing complexity and workload for clinical trial...

R&D

hVIVO Future of RSV research

Sponsored

Rethinking clinical research: The case for human challenge t...

R&D

Interview at LSX 2026 with Paulo Neves

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

Editor's Picks

GBL joins CVC in €10.7bn takeover bid for Recordati

After refusing to resign, CDER head Høeg is fired

As Ebola deaths climb, search begins for vaccine

NICE changes stance on Genmab's cervical cancer drug

Remepy's hybrid Parkinson's therapy poised for phase 3

News

Paris skyline, Eiffel Tower

France 'first EU country to cover obesity drugs'

France's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company